WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010023457) NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/023457    International Application No.:    PCT/GB2009/002096
Publication Date: 04.03.2010 International Filing Date: 28.08.2009
IPC:
A61K 31/7072 (2006.01), C07H 19/073 (2006.01), C07H 19/067 (2006.01)
Applicants: IMPERIAL INNOVATIONS LIMITED [GB/GB]; Electrical and Electronic Building Level 12 Imperial College London SW7 2AZ (GB) (For All Designated States Except US).
ABOAGYE, Eric, Ofori [GB/GB]; (GB) (For US Only).
SMITH, Graham [GB/GB]; (GB) (For US Only)
Inventors: ABOAGYE, Eric, Ofori; (GB).
SMITH, Graham; (GB)
Agent: PILKINGTON, Stephanie; Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD (GB)
Priority Data:
0815831.3 01.09.2008 GB
Title (EN) NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS
(FR) ANALOGUES DE NUCLÉOSIDE UTILES EN TANT QU’AGENTS D’IMAGERIE DE TOMOGRAPHIE PAR ÉMISSION DE POSITONS (PET)
Abstract: front page image
(EN)The invention provides compounds that comprise a 4'-thio nucleoside that is a derivative of 4'-thiothymidine or 4'-thio-2'-deoxyuridine comprising a positron or single photon emitting radioisotope or corresponding non-radioactive isotope attached via a triazole link to the N-3 position. Methods for preparing such compounds and uses of the compounds in medicine are also provided.
(FR)La présente invention concerne des composés qui comprennent un 4'-thio-nucléoside qui est un dérivé de 4'-thiothymidine ou de 4'-thio-2'-désoxyuridine comprenant un radio-isotope émetteur de positon ou de photon unique ou un isotope non radioactif correspondant lié par l’intermédiaire d’une liaison triazole à la position N-3. La présente invention concerne en outre des procédés pour préparer de tels composés et des utilisations des composés en médecine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)